Records containing: Ovary Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2026-10-07INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
-
CLINICAL_TRIALS study record update · 2026-09-16Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
-
CLINICAL_TRIALS study results posted · 2026-07-02Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase II Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine-gynx and Olaparib in Recurrent Platinum Sensitive Ovarian, Peritoneal, and Fallopian Tube Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-24The Impact of Alternate Day Fasting After Surgery for Patients Undergoing chemoTherapy (FAST Study)
-
CLINICAL_TRIALS study record update · 2026-03-23A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment
-
CLINICAL_TRIALS study record update · 2026-03-09Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
-
CLINICAL_TRIALS study record update · 2026-03-04A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
-
CLINICAL_TRIALS study record update · 2026-02-20A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Autologous Logic-gated Tmod™ CAR T Products, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
-
CLINICAL_TRIALS study record update · 2025-11-12Multimedia Aid for Genetic Testing in Gynecologic Oncology
-
CLINICAL_TRIALS study record update · 2025-11-06Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-10-27A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-10-08No-Stoma Policy in Advanced Ovarian Cancer Surgery, Feasibility and Outcomes
-
CLINICAL_TRIALS study record update · 2025-10-02A Phase I/II Dose Escalation, Safety and Efficacy Study of Anti-NY-ESO-1 T Cell Receptor (TCR)-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
-
CLINICAL_TRIALS study record update · 2025-09-23A Pan-European Non-interventional, Retrospective Observational Cohort Study of Patients With BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer Treated With Olaparib Tablets in the First-line Maintenance Setting
-
CLINICAL_TRIALS study record update · 2025-09-22A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers)
-
CLINICAL_TRIALS study record update · 2025-08-20A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers
-
CLINICAL_TRIALS study record update · 2025-07-31An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-07-20First-in-Human, Dose Finding, Open Label Phase 1A-1B Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-16Overall Survival Following Interval and Delayed Cytoreduction Surgery in Advanced Stage Ovarian Cancer: a Pragmatic Phase III Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-07-08Disitamab Vedotin (RC48) in Combination With AK104 (PD-1/CTLA-4 Bispecific) and Bevacizumab for the Treatment of Recurrent and Persistent Clear Cell Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-06-19A PHASE 2 EFFICACY TRIAL OF INTENSIVE LOCOREGIONAL CHEMOIMMUNOTHERAPY FOR ADVANCED STAGE OVARIAN CANCER AND TUMOR-SPECIFIC INTRANODAL AUTOLOGOUS ALPHA-DC1 VACCINES
-
CLINICAL_TRIALS study record update · 2025-06-12Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
-
CLINICAL_TRIALS study record update · 2025-04-29Patient-Tailored Physical Activity Intervention Among Older Women With Gynecologic Cancers Undergoing Chemotherapy (Fit4Treatment)